Literature DB >> 2565927

Variability of CR2 gene products is due to alternative exon usage and different CR2 alleles.

L E Toothaker1, A J Henjes, J J Weis.   

Abstract

The gene encoding human complement receptor 2 (CR2) lies within a cluster of genes on human chromosome 1. Polymorphisms have been described for several of these genes or gene products. To examine any possible polymorphisms in the CR2 gene product we have analyzed the CR2 transcriptional products for variations via alternative exon usage and for the presence of different CR2 alleles within the human population. This analysis has suggested that an exon encoding a 60 amino acid short consensus repeat can be alternatively spliced. Evidence for two transcriptional products has been found in a variety of transformed human B cells and two human tonsils. Interestingly the ratio of the two forms of mRNA, that which includes the alternative exon and that which does not, is not constant when examining the RNA from these sources. In addition to the variation introduced by the alternatively spliced product, there appears to exist in the human population at least three different alleles for CR2. These alleles have been defined by multiple nucleotide changes which are not silent but which alter the amino acid encoded at that site. However, we have not identified allelic variants of CR2 which would produce a product varying in the number of long homologous repeats, as has been identified for the various alleles of the closely related protein, human complement receptor 1.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2565927

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  9 in total

Review 1.  Epstein-Barr virus tissue tropism: a major determinant of immunopathogenesis.

Authors:  L Hutt-Fletcher
Journal:  Springer Semin Immunopathol       Date:  1991

2.  Origin and properties of soluble CD21 (CR2) in human blood.

Authors:  N R Ling; D L Hardie; G D Johnson; I C MacLennan
Journal:  Clin Exp Immunol       Date:  1998-09       Impact factor: 4.330

3.  Alternatively spliced RNAs encode several isoforms of CD46 (MCP), a regulator of complement activation.

Authors:  D F Purcell; S M Russell; N J Deacon; M A Brown; D J Hooker; I F McKenzie
Journal:  Immunogenetics       Date:  1991       Impact factor: 2.846

Review 4.  CD19 function in central and peripheral B-cell development.

Authors:  Christopher J Del Nagro; Dennis C Otero; Amy N Anzelon; Sidne A Omori; Ravi V Kolla; Robert C Rickert
Journal:  Immunol Res       Date:  2005       Impact factor: 2.829

5.  Epstein Barr virus/complement C3d receptor is an interferon alpha receptor.

Authors:  A X Delcayre; F Salas; S Mathur; K Kovats; M Lotz; W Lernhardt
Journal:  EMBO J       Date:  1991-04       Impact factor: 11.598

6.  Two conformational forms of target-bound iC3b that distinctively bind complement receptors 1 and 2 and two specific monoclonal antibodies.

Authors:  Ulf R Nilsson; Lillemor Funke; Bo Nilsson; Kristina N Ekdahl
Journal:  Ups J Med Sci       Date:  2010-11-11       Impact factor: 2.384

7.  Determination of the structural basis for selective binding of Epstein-Barr virus to human complement receptor type 2.

Authors:  D R Martin; A Yuryev; K R Kalli; D T Fearon; J M Ahearn
Journal:  J Exp Med       Date:  1991-12-01       Impact factor: 14.307

8.  New nucleotide sequence data on the EMBL File Server.

Authors: 
Journal:  Nucleic Acids Res       Date:  1989-09-12       Impact factor: 16.971

9.  Characterization of an Epstein-Barr virus receptor on human epithelial cells.

Authors:  M Birkenbach; X Tong; L E Bradbury; T F Tedder; E Kieff
Journal:  J Exp Med       Date:  1992-11-01       Impact factor: 14.307

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.